ELEVANCE HEALTH INC (ELV) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:ELV • US0367521038

340.6 USD
+1.95 (+0.58%)
At close: Feb 4, 2026
340.6 USD
0 (0%)
After Hours: 2/4/2026, 8:16:15 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ELV. ELV was compared to 102 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of ELV while its profitability can be described as average. ELV has a correct valuation and a medium growth rate. ELV also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ELV was profitable.
  • ELV had a positive operating cash flow in the past year.
  • ELV had positive earnings in each of the past 5 years.
  • ELV had a positive operating cash flow in each of the past 5 years.
ELV Yearly Net Income VS EBIT VS OCF VS FCFELV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

1.2 Ratios

  • With a decent Return On Assets value of 4.66%, ELV is doing good in the industry, outperforming 74.51% of the companies in the same industry.
  • ELV has a better Return On Equity (12.90%) than 78.43% of its industry peers.
  • ELV has a Return On Invested Capital (5.39%) which is comparable to the rest of the industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ELV is below the industry average of 9.16%.
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROIC 5.39%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.61%
ROIC(5y)7.03%
ELV Yearly ROA, ROE, ROICELV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of ELV (2.84%) is better than 65.69% of its industry peers.
  • ELV's Profit Margin has declined in the last couple of years.
  • ELV's Operating Margin of 4.07% is in line compared to the rest of the industry. ELV outperforms 59.80% of its industry peers.
  • ELV's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.07%
PM (TTM) 2.84%
GM N/A
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
ELV Yearly Profit, Operating, Gross MarginsELV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

More info and screens

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ELV is destroying value.
  • ELV has less shares outstanding than it did 1 year ago.
  • ELV has less shares outstanding than it did 5 years ago.
  • ELV has a better debt/assets ratio than last year.
ELV Yearly Shares OutstandingELV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
ELV Yearly Total Debt VS Total AssetsELV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • ELV has a debt to FCF ratio of 10.10. This is a negative value and a sign of low solvency as ELV would need 10.10 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 10.10, ELV is in line with its industry, outperforming 46.08% of the companies in the same industry.
  • A Debt/Equity ratio of 0.71 indicates that ELV is somewhat dependend on debt financing.
  • ELV's Debt to Equity ratio of 0.71 is in line compared to the rest of the industry. ELV outperforms 53.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Altman-Z N/A
ROIC/WACC0.63
WACC8.55%
ELV Yearly LT Debt VS Equity VS FCFELV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B 40B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
ELV Yearly Current Assets VS Current LiabilitesELV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

More info and screens

5

3. Growth

3.1 Past

  • ELV shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.49%.
  • Measured over the past 5 years, ELV shows a small growth in Earnings Per Share. The EPS has been growing by 6.12% on average per year.
  • The Revenue has grown by 12.62% in the past year. This is quite good.
  • Measured over the past years, ELV shows a quite strong growth in Revenue. The Revenue has been growing by 10.32% on average per year.
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%

3.2 Future

  • Based on estimates for the next years, ELV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.74% on average per year.
  • ELV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.60% yearly.
EPS Next Y-13.28%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
EPS Next 5Y13.74%
Revenue Next Year-2.33%
Revenue Next 2Y0.27%
Revenue Next 3Y1.79%
Revenue Next 5Y2.6%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ELV Yearly Revenue VS EstimatesELV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50B 100B 150B 200B
ELV Yearly EPS VS EstimatesELV Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.29 indicates a reasonable valuation of ELV.
  • Based on the Price/Earnings ratio, ELV is valued cheaply inside the industry as 85.29% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of ELV to the average of the S&P500 Index (28.25), we can say ELV is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 13.02, ELV is valued correctly.
  • ELV's Price/Forward Earnings ratio is rather cheap when compared to the industry. ELV is cheaper than 84.31% of the companies in the same industry.
  • ELV's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.50.
Industry RankSector Rank
PE 11.29
Fwd PE 13.02
ELV Price Earnings VS Forward Price EarningsELV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ELV is valued a bit cheaper than 72.55% of the companies in the same industry.
  • ELV's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 23.85
EV/EBITDA 10.11
ELV Per share dataELV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 200 400 600 800

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.85
EPS Next 2Y-1.35%
EPS Next 3Y4.53%

More info and screens

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 2.01%, ELV has a reasonable but not impressive dividend return.
  • ELV's Dividend Yield is rather good when compared to the industry average which is at 0.47. ELV pays more dividend than 92.16% of the companies in the same industry.
  • ELV's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.01%

5.2 History

  • The dividend of ELV is nicely growing with an annual growth rate of 12.16%!
  • ELV has paid a dividend for at least 10 years, which is a reliable track record.
  • ELV has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)12.16%
Div Incr Years13
Div Non Decr Years13
ELV Yearly Dividends per shareELV Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

5.3 Sustainability

  • ELV pays out 27.00% of its income as dividend. This is a sustainable payout ratio.
  • ELV's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP27%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
ELV Yearly Income VS Free CF VS DividendELV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B
ELV Dividend Payout.ELV Dividend Payout, showing the Payout Ratio.ELV Dividend Payout.PayoutRetained Earnings

More info and screens

ELEVANCE HEALTH INC

NYSE:ELV (2/4/2026, 8:16:15 PM)

After market: 340.6 0 (0%)

340.6

+1.95 (+0.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)01-28
Earnings (Next)04-20
Inst Owners91.68%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner Change0.01%
Market Cap75.69B
Revenue(TTM)199.13B
Net Income(TTM)5.66B
Analysts73.57
Price Target401.08 (17.76%)
Short Float %1.66%
Short Ratio2.27
Dividend
Industry RankSector Rank
Dividend Yield 2.01%
Yearly Dividend6.8
Dividend Growth(5Y)12.16%
DP27%
Div Incr Years13
Div Non Decr Years13
Ex-Date03-10
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.74%
Min EPS beat(2)6.46%
Max EPS beat(2)21.02%
EPS beat(4)3
Avg EPS beat(4)7.33%
Min EPS beat(4)-2.26%
Max EPS beat(4)21.02%
EPS beat(8)6
Avg EPS beat(8)1.93%
EPS beat(12)9
Avg EPS beat(12)1.87%
EPS beat(16)12
Avg EPS beat(16)2.12%
Revenue beat(2)1
Avg Revenue beat(2)-0.77%
Min Revenue beat(2)-2%
Max Revenue beat(2)0.45%
Revenue beat(4)3
Avg Revenue beat(4)1.05%
Min Revenue beat(4)-2%
Max Revenue beat(4)4.3%
Revenue beat(8)4
Avg Revenue beat(8)0.4%
Revenue beat(12)6
Avg Revenue beat(12)0.63%
Revenue beat(16)9
Avg Revenue beat(16)0.61%
PT rev (1m)1.06%
PT rev (3m)1.07%
EPS NQ rev (1m)-1.73%
EPS NQ rev (3m)-3%
EPS NY rev (1m)-0.03%
EPS NY rev (3m)0.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.19%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.55%
Valuation
Industry RankSector Rank
PE 11.29
Fwd PE 13.02
P/S 0.38
P/FCF 23.85
P/OCF 17.64
P/B 1.72
P/tB 17.45
EV/EBITDA 10.11
EPS(TTM)30.17
EY8.86%
EPS(NY)26.16
Fwd EY7.68%
FCF(TTM)14.28
FCFY4.19%
OCF(TTM)19.3
OCFY5.67%
SpS895.99
BVpS197.45
TBVpS19.52
PEG (NY)N/A
PEG (5Y)1.85
Graham Number366.11
Profitability
Industry RankSector Rank
ROA 4.66%
ROE 12.9%
ROCE 6.75%
ROIC 5.39%
ROICexc 5.85%
ROICexgc 10.18%
OM 4.07%
PM (TTM) 2.84%
GM N/A
FCFM 1.59%
ROA(3y)5.09%
ROA(5y)5.45%
ROE(3y)14.2%
ROE(5y)15.16%
ROIC(3y)6.61%
ROIC(5y)7.03%
ROICexc(3y)7.13%
ROICexc(5y)7.56%
ROICexgc(3y)13.02%
ROICexgc(5y)14.04%
ROCE(3y)8.29%
ROCE(5y)8.81%
ROICexgc growth 3Y-11.47%
ROICexgc growth 5Y-9.01%
ROICexc growth 3Y-9.05%
ROICexc growth 5Y-6.9%
OM growth 3Y-9.09%
OM growth 5Y-8.43%
PM growth 3Y-8.92%
PM growth 5Y-5.39%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.64
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 10.1
Debt/EBITDA 3.2
Cap/Depr 72.19%
Cap/Sales 0.56%
Interest Coverage 250
Cash Conversion 44.42%
Profit Quality 56.06%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC8.55%
ROIC/WACC0.63
Cap/Depr(3y)78.87%
Cap/Depr(5y)77.78%
Cap/Sales(3y)0.68%
Cap/Sales(5y)0.71%
Profit Quality(3y)81.36%
Profit Quality(5y)97.25%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.49%
EPS 3Y1.27%
EPS 5Y6.12%
EPS Q2Q%-13.28%
EPS Next Y-13.28%
EPS Next 2Y-1.35%
EPS Next 3Y4.53%
EPS Next 5Y13.74%
Revenue 1Y (TTM)12.62%
Revenue growth 3Y8.34%
Revenue growth 5Y10.32%
Sales Q2Q%9.61%
Revenue Next Year-2.33%
Revenue Next 2Y0.27%
Revenue Next 3Y1.79%
Revenue Next 5Y2.6%
EBIT growth 1Y-11.4%
EBIT growth 3Y-1.51%
EBIT growth 5Y1.02%
EBIT Next Year1.62%
EBIT Next 3Y13.19%
EBIT Next 5Y13.39%
FCF growth 1Y-29.25%
FCF growth 3Y-24.06%
FCF growth 5Y-19.97%
OCF growth 1Y-25.29%
OCF growth 3Y-20.06%
OCF growth 5Y-16.69%

ELEVANCE HEALTH INC / ELV FAQ

Can you provide the ChartMill fundamental rating for ELEVANCE HEALTH INC?

ChartMill assigns a fundamental rating of 4 / 10 to ELV.


Can you provide the valuation status for ELEVANCE HEALTH INC?

ChartMill assigns a valuation rating of 5 / 10 to ELEVANCE HEALTH INC (ELV). This can be considered as Fairly Valued.


What is the profitability of ELV stock?

ELEVANCE HEALTH INC (ELV) has a profitability rating of 4 / 10.


What are the PE and PB ratios of ELEVANCE HEALTH INC (ELV) stock?

The Price/Earnings (PE) ratio for ELEVANCE HEALTH INC (ELV) is 11.29 and the Price/Book (PB) ratio is 1.72.


Can you provide the expected EPS growth for ELV stock?

The Earnings per Share (EPS) of ELEVANCE HEALTH INC (ELV) is expected to decline by -13.28% in the next year.